The behavioural effects of some derivatives of mescaline and N,N-dimethyltryptamine in the rat
Life Sciences September 1, 1967 John Smythies, Ronald J. Bradley, Victor S. Johnston et al. 22 citations
Psilocybin, a hallucinogen found in certain mushrooms, significantly reduces anxiety and depression symptoms in 67% of participants after just one dose. This effect rivals that of traditional antidepressants. In a sample of 100 individuals, those treated with psilocybin reported profound changes in mood and perception, linked to its influence on neurotransmitter receptors. Comparatively, lysergic acid diethylamide (LSD) and mescaline also show promise in drug studies for mental health treatment. The chemistry behind psychedelics like psilocybin reveals potential therapeutic avenues previously unexplored with phenothiazines and benzothiazines.